Krystal Biotech Inc. (KRYS)

KRYS trades at $167.82, 11.9% above the near-term max pain of $150 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($75-$190), reflecting growing call interest at higher strikes. Key magnetic zone at 150 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KRYS shows an upward trend from 75 to 190, suggesting bullish positioning in longer-dated options. The 81% spread signals divergent expectations across timeframes. Most levels below 167.82 may cap rallies. Strong magnetic level at 150 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.